Literature DB >> 21559849

A study to investigate tanezumab in patients with interstitial cystitis/painful bladder syndrome.

Alexis E Te.   

Abstract

Entities:  

Year:  2011        PMID： 21559849     DOI： 10.1007/s11934-011-0194-0

Source DB:  PubMed          Journal:  Curr Urol Rep        ISSN： 1527-2737            Impact factor:   3.092


× No keyword cloud information.
  5 in total

1.  Nerve growth factor and pain.

Authors:  John N Wood
Journal:  N Engl J Med       Date:  2010-09-29       Impact factor: 91.245

2.  Hyperalgesia induced in the rat by the amino-terminal octapeptide of nerve growth factor.

Authors:  Y O Taiwo; J D Levine; R M Burch; J E Woo; W C Mobley
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-15       Impact factor: 11.205

Review 3.  Novel class of pain drugs based on antagonism of NGF.

Authors:  Franz F Hefti; Arnon Rosenthal; Patricia A Walicke; Sean Wyatt; German Vergara; David L Shelton; Alun M Davies
Journal:  Trends Pharmacol Sci       Date:  2005-12-27       Impact factor: 14.819

4.  Tanezumab for the treatment of pain from osteoarthritis of the knee.

Authors:  Nancy E Lane; Thomas J Schnitzer; Charles A Birbara; Masoud Mokhtarani; David L Shelton; Mike D Smith; Mark T Brown
Journal:  N Engl J Med       Date:  2010-09-29       Impact factor: 91.245

5.  The biological effects of endogenous nerve growth factor on adult sensory neurons revealed by a trkA-IgG fusion molecule.

Authors:  S B McMahon; D L Bennett; J V Priestley; D L Shelton
Journal:  Nat Med       Date:  1995-08       Impact factor: 53.440
  5 in total
  5 in total

Review 1.  Current understanding of the neuropathophysiology of pain in chronic pancreatitis.

Authors:  Amporn Atsawarungruangkit; Supot Pongprasobchai
Journal:  World J Gastrointest Pathophysiol       Date:  2015-11-15

Review 2.  Unraveling the mystery of pain in chronic pancreatitis.

Authors:  Pankaj Jay Pasricha
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-01-24       Impact factor: 46.802

3.  Systemic Depletion of Nerve Growth Factor Inhibits Disease Progression in a Genetically Engineered Model of Pancreatic Ductal Adenocarcinoma.

Authors:  Jami L Saloman; Aatur D Singhi; Douglas J Hartman; Daniel P Normolle; Kathryn M Albers; Brian M Davis
Journal:  Pancreas       Date:  2018-08       Impact factor: 3.327

4.  Changes resembling complex regional pain syndrome following surgery and immobilization.

Authors:  Alison Pepper; Wenwu Li; Wade S Kingery; Martin S Angst; Catherine M Curtin; J David Clark
Journal:  J Pain       Date:  2013-02-28       Impact factor: 5.820

Review 5.  Evidence for bladder urothelial pathophysiology in functional bladder disorders.

Authors:  Susan K Keay; Lori A Birder; Toby C Chai
Journal:  Biomed Res Int       Date:  2014-05-08       Impact factor: 3.411
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.